The purpose of this study was to develop and validate an optimal radiomics-based model for diagnosis of advanced liver fibrosis. Firstly, multimodal MRI was performed before and 20 minutes after Gd-EOB-DTPA administration. Secondly, the clinical diagnosis model, fusion radiomics signature and radiomics nomogram model were established in the training cohort. Finally, the diagnostic value of three models was confirmed in the validation cohort.
This abstract and the presentation materials are available to members only; a login is required.